FGF21 and chronic kidney disease: Again, Fgf21−/− CKD mice administered with the AAV8-FGF21 had high serum corticosterone levels comparable with those in wild-type CKD mice (Fig. 5b), indicating that FGF21 is responsible for the increased corticosterone in this CKD model.